Manij Joshi

Trial Pharmacist & Quality Assurance Officer

Manij serves as a trial pharmacist on the multi-country, double-blinded, randomized controlled trial ACT South Asia at OUCRU.

His research interests include infectious diseases, antimicrobial use and resistance, antihypertensive drugs, and oral hypoglycemic drugs.

In addition to his role as a trial pharmacist, Manij works as a QA officer in a cohort study that follows a randomized controlled trial. The study is titled ‘Assessing the medium-term impact of a Vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepali children.”

Furthermore, Manij also worked as a vaccine logistics officer in a double-blinded randomized controlled trial of the Typhoid Conjugate Vaccine (TCV) from December 19, 2019, to March 31, 2022. The study is titled ‘Assessing the impact of Vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepali children – a phase III trial.’

Publications

Mila Shakya, Merryn Voysey, Katherine Theiss-Nyland, Rachel Colin-Jones, Dikshya Pant, Anup Adhikari, Susan Tonks, Yama F Mujadidi, Peter O’Reilly, Olga Mazur, Sarah Kelly, Xinxue Liu, Archana Maharjan, Ashata Dahal, Naheeda Haque, Anisha Pradhan, Suchita Shrestha, Manij Joshi, Nicola Smith, Jennifer Hill, Jenny Clarke, Lisa Stockdale, Elizabeth Jones, Timothy Lubinda, Binod Bajracharya, Sabina Dongol, Abhilasha Karkey, Stephen Baker, Gordan Dougan, Virginia E Pitzer, Kathleen M Neuzil, Shrijana Shrestha, Buddha Basnyat, Andrew J Pollard; TyVAC Nepal Team

Lancet Glob Health

November 1, 2021

DOI: 10.1016/S2214-109X(21)00346-6

Shakya M, Colin-Jones R, Theiss-Nyland K, Voysey M, Pant D, Smith N, Liu X, Tonks S, Mazur O, Farooq YG, Clarke J, Hill J, Adhikari A, Dongol S, Karkey A, Bajracharya B, Kelly S, Gurung M, Baker S, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ; TyVAC Nepal Study Team

N Engl J Med

December 5, 2019

DOI: 10.1056/NEJMoa1905047

LEARN MORE

Projects